NASDAQ:NMRD
Nemaura Medical Inc. Stock Company Profile
$0.0542
-0.0025 (-4.39%)
At Close: Apr 26, 2024
Information
57 West 57th Street, Manhattan
New York NY 10019
646 416 7912
nemauramedical.com
Industry: Medical Devices
Sector: Healthcare
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
